share_log

UBS Maintains Buy on DaVita, Lowers Price Target to $113

Benzinga ·  Nov 17, 2023 10:58

UBS analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Buy and lowers the price target from $142 to $113.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment